Deaf-owned software company Wavio announced a strategic partnership with AREA 23, an FCB Health Network Company, which includes a major investment deal for the development and product launch of “See Sound.” Created by AREA 23 and Wavio, the revolutionary home device is scheduled to launch during 2020. The partnership provides the FCB Health Network with company equity in Wavio and revenue share on product sales.

A smart insulin device under development could revolutionize how glucose levels are monitored in diabetes patients and deliver insulin doses when necessary.

The first new asthma pill in decades has produced promising results in a small study, potentially paving the way for another treatment option by the end of the decade.